{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:30:53Z","timestamp":1792801853449,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science, Technology & Innovation Funding Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sweating is a physiologic mechanism of human thermoregulation. Hyperhidrosis is defined as a somatic disorder where the sweating is exaggerated in an exact area because the sweat glands are hyperfunctioning. It negatively affects the quality of life of the patients. We aim to investigate patient satisfaction and the effectiveness of oxybutynin in treating hyperhidrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We prospectively registered the protocol of this systematic review and meta-analysis on PROSPERO (CRD 42022342667). This systematic review and meta-analysis were reported according to the PRISMA statement guidelines. We searched three electronic databases (PubMed, Scopus, Web of Science) from inception until June 2, 2022, using MeSH terms. We include studies comparing patients with hyperhidrosis who received oxybutynin or a placebo. We assessed the risk of bias using the Cochrane risk of bias assessment tool (ROB2) for randomized controlled trials. The risk ratio was calculated for categorical variables, and the mean difference was calculated for continuous variables using the random effect model with 95% confidence intervals (CI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Six studies were included in the meta-analysis, with a total of 293 patients. In all studies, patients were assigned to receive either Oxybutynin or Placebo. Oxybutynin represented an HDSS improvement (RR\u2009=\u20091.68 95% CI [1.21, 2.33], <jats:italic>p<\/jats:italic>\u2009=\u20090.002). It also can improve the quality of life. There is no difference between oxybutynin and placebo regarding dry mouth (RR\u2009=\u20091.68 95% CI [1.21, 2.33], <jats:italic>p<\/jats:italic>\u2009=\u20090.002).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study suggests that using oxybutynin as a treatment for hyperhidrosis is significant and needs to be highlighted for clinicians. However, more clinical trials are needed to grasp the optimum benefit.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00403-023-02587-5","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T13:02:33Z","timestamp":1677934953000},"page":"2215-2226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"315","author":[{"given":"Mohamed","family":"El-Samahy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Mouffokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Badawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Amro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Ahmed","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"issue":"2","key":"2587_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51(2):241\u2013248. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.040","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2587_CR2","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jvs.2011.12.039","volume":"55","author":"N Wolosker","year":"2012","unstructured":"Wolosker N, de Campos JRM, Kauffman P, Puech-Le\u00e3o P (2012) A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg 55(6):1696\u20131700. https:\/\/doi.org\/10.1016\/j.jvs.2011.12.039","journal-title":"J Vasc Surg"},{"issue":"556","key":"2587_CR3","first-page":"710","volume":"13","author":"S Menzinger","year":"2017","unstructured":"Menzinger S, Quenan S (2017) Evaluation and management of hyperhidrosis. Rev Med Suisse 13(556):710\u2013714","journal-title":"Rev Med Suisse"},{"issue":"6","key":"2587_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1590\/abd1806-4841.20165358","volume":"91","author":"FR Romero","year":"2016","unstructured":"Romero FR, Haddad GR, Miot HA, Cataneo DC (2016) Palmar hyperhidrosis: clinical, pathophysiological, diagnostic and therapeutic aspects. An Bras Dermatol 91(6):716\u2013725. https:\/\/doi.org\/10.1590\/abd1806-4841.20165358","journal-title":"An Bras Dermatol"},{"issue":"3","key":"2587_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2018.12.071","volume":"81","author":"S Nawrocki","year":"2019","unstructured":"Nawrocki S, Cha J (2019) The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: etiology and clinical work-up. J Am Acad Dermatol 81(3):657\u2013666. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.071","journal-title":"J Am Acad Dermatol"},{"key":"2587_CR6","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1136\/bmj.f6800","volume":"347","author":"RA Benson","year":"2013","unstructured":"Benson RA, Palin R, Holt PJE, Loftus IM (2013) Diagnosis and management of hyperhidrosis. BMJ 347:6800. https:\/\/doi.org\/10.1136\/bmj.f6800","journal-title":"BMJ"},{"issue":"4","key":"2587_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1524-4725.2000.00604.x","volume":"26","author":"JM Swinehart","year":"2000","unstructured":"Swinehart JM (2000) Treatment of axillary hyperhidrosis: combination of the starch-iodine test with the tumescent liposuction technique. Dermatol Surg 26(4):392\u2013396. https:\/\/doi.org\/10.1046\/j.1524-4725.2000.00604.x","journal-title":"Dermatol Surg"},{"issue":"8","key":"2587_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1524-4725.2007.33192.x","volume":"33","author":"N Solish","year":"2007","unstructured":"Solish N et al (2007) A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 33(8):908\u2013923. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33192.x","journal-title":"Dermatol Surg"},{"issue":"3","key":"2587_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK (1994) Dermatology life quality index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol 19(3):210\u2013216. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"2587_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2340\/00015555-1464","volume":"93","author":"K Rosell","year":"2013","unstructured":"Rosell K, Hymnelius K, Swartling C (2013) Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol 93(3):335\u2013339. https:\/\/doi.org\/10.2340\/00015555-1464","journal-title":"Acta Derm Venereol"},{"key":"2587_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/308650","volume":"2014","author":"A Kouris","year":"2014","unstructured":"Kouris A, Armyra K, Christodoulou C, Karimali P, Karypidis D, Kontochristopoulos G (2014) Quality of life in patients with focal hyperhidrosis before and after treatment with botulinum toxin A. ISRN Dermatol. 2014:308650. https:\/\/doi.org\/10.1155\/2014\/308650","journal-title":"ISRN Dermatol."},{"issue":"4","key":"2587_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.det.2014.06.004","volume":"32","author":"H Hamm","year":"2014","unstructured":"Hamm H (2014) Impact of hyperhidrosis on quality of life and its assessment. Dermatol Clin 32(4):467\u2013476. https:\/\/doi.org\/10.1016\/j.det.2014.06.004","journal-title":"Dermatol Clin"},{"issue":"9","key":"2587_CR13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/14740338.2017.1354983","volume":"16","author":"C Hosp","year":"2017","unstructured":"Hosp C, Hamm H (2017) Safety of available and emerging drug therapies for hyperhidrosis. Expert Opin Drug Saf 16(9):1039\u20131049. https:\/\/doi.org\/10.1080\/14740338.2017.1354983","journal-title":"Expert Opin Drug Saf"},{"key":"2587_CR14","volume-title":"StatPearls","author":"J Brackenrich","year":"2022","unstructured":"Brackenrich J, Fagg C (2022) Hyperhidrosis. StatPearls. StatPearls Publishing, Treasure Island"},{"key":"2587_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000446786","volume":"51","author":"T Fujimoto","year":"2016","unstructured":"Fujimoto T (2016) Pathophysiology and treatment of hyperhidrosis. Curr Probl Dermatol 51:86\u201393. https:\/\/doi.org\/10.1159\/000446786","journal-title":"Curr Probl Dermatol"},{"issue":"4","key":"2587_CR16","first-page":"465","volume":"83","author":"JW Saenz","year":"2011","unstructured":"Saenz JW, Sams RW, Jamieson B (2011) FPIN\u2019s clinical inquiries. Treatment of hyperhidrosis. Am Fam Physician 83(4):465\u2013466","journal-title":"Am Fam Physician"},{"issue":"2","key":"2587_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J et al (2004) Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 51(2):274\u2013286. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.029","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2587_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.det.2014.06.013","volume":"32","author":"ART de Almeida","year":"2014","unstructured":"de Almeida ART, Montagner S (2014) Botulinum toxin for axillary hyperhidrosis. Dermatol Clin 32(4):495\u2013504. https:\/\/doi.org\/10.1016\/j.det.2014.06.013","journal-title":"Dermatol Clin"},{"issue":"9","key":"2587_CR19","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/imj.15489","volume":"51","author":"J Farrell","year":"2021","unstructured":"Farrell J, Stewart T, Singh B, Singh G, Rosen R (2021) Retrospective analysis of the efficacy and duration of botulinum toxin A injections in 30 patients with palmar hyperhidrosis. Intern Med J 51(9):1517\u20131521. https:\/\/doi.org\/10.1111\/imj.15489","journal-title":"Intern Med J"},{"issue":"3","key":"2587_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jaad.2018.11.066","volume":"81","author":"S Nawrocki","year":"2019","unstructured":"Nawrocki S, Cha J (2019) The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: therapeutic options. J Am Acad Dermatol 81(3):669\u2013680. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.066","journal-title":"J Am Acad Dermatol"},{"key":"2587_CR21","unstructured":"Pharmacologic treatment of antidepressant-induced excessive sweating: a systematic review. https:\/\/www.archivespsy.com\/article\/48-1\/pharmacologic-treatment-of-antidepressant-induced-excessive-sweating-a-systematic-review\/index.html (accessed Jul. 24, 2022)."},{"issue":"3","key":"2587_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1212\/wnl.38.3.506-a","volume":"38","author":"P LeWitt","year":"1988","unstructured":"LeWitt P (1988) Hyperhidrosis and hypothermia responsive to oxybutynin. Neurology 38(3):506\u2013507. https:\/\/doi.org\/10.1212\/wnl.38.3.506-a","journal-title":"Neurology"},{"issue":"9","key":"2587_CR23","first-page":"326","volume":"64","author":"GS Mijnhout","year":"2006","unstructured":"Mijnhout GS, Kloosterman H, Simsek S, Strack van Schijndel RJM, Netelenbos JC (2006) Oxybutynin: dry days for patients with hyperhidrosis. Neth J Med 64(9):326\u2013328","journal-title":"Neth J Med"},{"issue":"4","key":"2587_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/archderm.143.4.544","volume":"143","author":"M Schollhammer","year":"2007","unstructured":"Schollhammer M, Misery L (2007) Treatment of hyperhidrosis with oxybutynin. Arch Dermatol 143(4):544\u2013545. https:\/\/doi.org\/10.1001\/archderm.143.4.544","journal-title":"Arch Dermatol"},{"issue":"9","key":"2587_CR25","first-page":"356","volume":"65","author":"JD Lefrandt","year":"2007","unstructured":"Lefrandt JD, Maurer JM (2007) Oxybutynin for hyperhidrosis. Neth J Med 65(9):356","journal-title":"Neth J Med"},{"key":"2587_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906. https:\/\/doi.org\/10.1016\/j.ijsu.2021.105906","journal-title":"Int J Surg"},{"issue":"1","key":"2587_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13643-021-01850-y","volume":"10","author":"HJ Seo","year":"2021","unstructured":"Seo HJ et al (2021) Peer support for smoking cessation: a protocol of systematic review and meta-analysis. Syst Rev 10(1):296. https:\/\/doi.org\/10.1186\/s13643-021-01850-y","journal-title":"Syst Rev"},{"key":"2587_CR28","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"7109","key":"2587_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"issue":"1","key":"2587_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0022-5347(17)41482-0","volume":"140","author":"JG Ouslander","year":"1988","unstructured":"Ouslander JG, Blaustein J, Connor A, Orzeck S, Yong CL (1988) Pharmacokinetics and clinical effects of oxybutynin in geriatric patients. J Urol 140(1):47\u201350. https:\/\/doi.org\/10.1016\/s0022-5347(17)41482-0","journal-title":"J Urol"},{"issue":"6","key":"2587_CR31","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/jdv.14081","volume":"31","author":"L Cruddas","year":"2017","unstructured":"Cruddas L, Baker DM (2017) Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review. J Eur Acad Dermatol Venereol 31(6):952\u2013963. https:\/\/doi.org\/10.1111\/jdv.14081","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2587_CR32","first-page":"94","volume":"23","author":"E Zur","year":"2019","unstructured":"Zur E (2019) Topical treatment of primary focal hyperhidrosis, part 2. Int J Pharm Compd 23(2):94\u2013104","journal-title":"Int J Pharm Compd"},{"issue":"5","key":"2587_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/pde.12385","volume":"32","author":"N Wolosker","year":"2015","unstructured":"Wolosker N et al (2015) Long-term efficacy of oxybutynin for palmar and plantar hyperhidrosis in children younger than 14 years. Pediatr Dermatol 32(5):663\u2013667. https:\/\/doi.org\/10.1111\/pde.12385","journal-title":"Pediatr Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02587-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T06:04:14Z","timestamp":1693202654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02587-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2587"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02587-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"1 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The protocol of this study was registered on PROSPERO (CRD 42022342667).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protocol registration"}}]}}